Skip to main content
. Author manuscript; available in PMC: 2016 Jul 1.
Published in final edited form as: Circ Heart Fail. 2015 May 18;8(4):702–708. doi: 10.1161/CIRCHEARTFAILURE.115.002097

Table 4.

Association of time-updated Kansas City Cardiomyopathy Questionnaire (KCCQ) score with incident heart failure in the following year

KCCQ Score ≤74.5 74.6–91.7 91.8–99.0 >99

OR (95% CI) p OR (95% CI) P OR (95% CI) P
Unadjusted 6.77 (3.75 – 12.23) <0.001 4.54 (2.49 – 8.28) <0.001 1.68 (0.86 – 3.30) 0.13 ref
Demographic Variables* 6.17 (3.40 – 11.18) <0.001 3.99 (2.18 – 7.31) <0.001 1.53 (0.78 – 3.01) 0.22 ref
Clinical Variables** 3.67 (1.90 – 7.10) <0.001 2.64 (1.37 – 5.07) 0.004 1.35 (0.66 – 2.77) 0.41 ref
Clinical Variables and NTproBNP*** 3.69 (1.88 – 7.27) <0.001 2.67 (1.37 – 5.21) 0.004 1.42 (0.68 – 2.95) 0.35 ref
Clinical Variables, NT-proBNP, LVH, and LV systolic dysfunction**** 3.30 (1.66 – 6.52) 0.001 2.18 (1.11 – 4.29) 0.02 1.23 (0.58 – 2.61) 0.58 ref
*

Adjusted for age, sex, ethnicity and site.

**

Adjusted for age, sex, ethnicity, site, diabetes status, history of cardiovascular disease, current smoking, alcohol use, 24-hour urine protein, estimated glomerular filtration rate, systolic blood pressure, body mass index, low-density lipoprotein and high-density lipoprotein levels.

***

Adjusted for above plus NT-proBNP level.

****

Adjusted for above plus LVH and LV systolic dysfunction

Abbreviations: KCCQ: Kansas City Cardiomyopathy Questionnaire; NT-proBNP: N-terminal pro-brain natriuretic peptide; OR: odds ratio; CI: confidence interval; LVH: left ventricular hypertrophy; ref.: reference quartile.